Good morning, everyone. There is something of a downpour drenching the Pharmalot corporate campus, nonetheless, our spirits remain as sunny as ever. We hope you feel the same. Meanwhile, the time has come to indulge in another cup of stimulation. So please join us we ready ourselves for another day. Hope yours is a good one and catch you soon...
Sanofi-Aventis & Covance Ink $2.2B, 10-Year Deal (Bloomberg News)
Big Jump In Brand-Name Meds For Seniors In 2011: Study (The Hill)
The Trials And Tribulations Of Malaria Vaccine Trials (Reuters)
Pfizer Arthritis Drug Worked Too Well (Bloomberg News)
Merck and AVEO End Collaboration On Lung Cancer Drug (Boston Globe)
Most NIH-Registered Trials Use Sites Outside No. America (OutsourcingPharma)
MediGene Cuts Workforce In Half (PharmaTimes)
Bidders Sought For Paras Pharmaceuticals (Economic Times)





